Key references: Lennox-Gastaut syndrome and other symptomatic generalised epilepsies

  • Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009;8(1):82–93. https://www.ncbi.nlm.nih.gov/pubmed/19081517
  • Glauser TA, Levisohn PM, Ritter F, Sachdeo RC. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia 2000;41 Suppl 1:S86–90. https://www.ncbi.nlm.nih.gov/pubmed/10768308
  • Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52(9):1882–7. https://www.ncbi.nlm.nih.gov/pubmed/10371538
  • Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 2015;56(7):1006–19. https://www.ncbi.nlm.nih.gov/pubmed/25851171